Dipòsit Digital de Documents de la UAB 10 registres trobats  La cerca s'ha fet en 0.00 segons. 
1.
469.5 KB Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes / Martin, Roman (University Medical Center Göttingen) ; Acha, Pamela (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ganster, Christina (University Medical Center Göttingen) ; Palomo Sanchís, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Dierks, Sascha (University Medical Center Göttingen) ; Fuster-Tormo, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ademà, Vera (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gómez-Marzo, Paula (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; De Haro, Nuri (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Solanes, Neus (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zamora, Lurdes (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Xicoy, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Shirneshan, Katayoon (University Medical Center Göttingen) ; Flach, Johanna (University Medical Center Göttingen) ; Braulke, Friederike (University Medical Center Göttingen) ; Schanz, Julie (University Medical Center Göttingen) ; Kominowski, Arkadiusz (University Medical Center Göttingen) ; Stromburg, Martin (University Medical Center Göttingen) ; Brockmann, Alina (University Medical Center Göttingen) ; Trümper, Lorenz (University Medical Center Göttingen) ; Sole, F (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Haase, Detlef (University Medical Center Göttingen) ; Universitat Autònoma de Barcelona
2018 - 10.1002/ajh.25089
American Journal of Hematology, Vol. 93 (april 2018) , p. E152-E154  
2.
9 p, 468.5 KB Preliminary data on COVID-19 in patients with hemoglobinopathies : A multicentre ICET-A study / de Sanctis, V. (Pediatric and Adolescent Outpatient Clinic. Quisisana Hospital) ; Canatan, D. (Antalya Genetic Diseases Diagnostic Center) ; Vives Corrons, Juan Luís (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Karimi, M. (Hematology Research Center. Shiraz University of Medical Sciences) ; Daar, S. (Department of Haematology. College of Medicine and Health Sciences. Sultan Qaboos University) ; Kattamis, C. (First Department of Paediatrics. National Kapodistrian University of Athens) ; Soliman, A.T. (Department of Pediatrics. University of Alexandria) ; Wali, Y. (Department of Paediatrics. Faculty of Medicine. Alexandria University) ; Alkindi, S. (Department of Haematology. College of Medicine and Health Sciences. Sultan Qaboos University) ; Huseynov, V. (Center of Thalassemia) ; Nasibova, A. (Center of Thalassemia) ; Tiryaki, T.O. (İstanbul University. Faculty of Medicine. Department of Hematology) ; Evim, M.S. (Uludag University. Medical Faculty. Dept. of Pediatric Hematology) ; Gunes, A.M. (Uludag University. Medical Faculty. Dept. of Pediatric Hematology) ; Karakas, Z. (Istanbul University. Istanbul Faculty of Medicine. Pediatric Hematology / Oncology) ; Christou, S. (Archibishop Makarios III Hospital. Thalassaemia Clinic) ; Campisi, S. (UOSD Thalassemia. Umberto I° Hospital) ; Zarei, T. (Hematology Research Center. Shiraz University of Medical Sciences) ; Khater, D. (Department of Pediatrics. Sultan Qaboos University) ; Oymak, Y. (Dr. Behcet Uz Children's Hospital) ; Kaleva, V. (Expert Center for Coagulopathies and Rare Anemias) ; Stoyanova, D. (Pediatric Hematoncology. University Hospital "Tzaritza Giovanna - ISUL") ; Banchev, A. (Pediatric Hematoncology. University Hospital "Tzaritza Giovanna - ISUL") ; Galati, M.C. (Pediatric Haematoncology. Pugliese-Ciaccio Hospital) ; Yassin, M.A. (Hematology Section. National Center for Cancer Care and Research. Hamad Medical Corporation. (HMC)) ; Kakar, S. (Pediatric Hematology Oncology. Department of Pediatrics. Dayanand Medical College and Hospital) ; Skafida, M. (First Department of Paediatrics. National Kapodistrian University of Athens) ; Kilinc, Y. (Pediatric Hematology Department. Çukurova University) ; Alyaarubi, S. (Pediatric Endocrinology Unit. Child Health Department. College of Medicine and Health Sciences. Sultan Qaboos University) ; Verdiyevas, N. (Center of Thalassemia) ; Stoeva, I. ("Screening and Functional Endocrine Diagnostics". University Paediatric Hospital) ; Raiola, G. (Department of Paediatrics. Pugliese-Ciaccio Hospital) ; Mariannis, D. (Royal Lancaster Infirmary) ; Ruggiero, L. (Pediatrician) ; Di Maio, S. (Emeritus Director in Pediatrics. "Santobono-Pausilipon" Children's Hospital) ; Universitat Autònoma de Barcelona
Objectives: This study aims to investigate, retrospectively, the epidemiological and clinical characteristics, laboratory results, radiologic findings, and outcomes of COVID-19 in patients with transfusion-dependent β thalassemia major (TM), β-thalassemia intermedia (TI) and sickle cell disease (SCD). [...]
2020 - 10.4084/MJHID.2020.046
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 12 Núm. 1 (2020) , p. e2020046  
3.
13 p, 1.0 MB Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia : A comparative study of the ALWP EBMT / Sanz, Jaime (Centro de Investigación Biomédica en Red de Cáncer) ; Galimard, J.E. (EBMT Paris Office. Hospital Saint Antoine) ; Labopin, M. (Department of Hematology. Hopital Saint Antoine. Sorbonne University) ; Afanasyev, B. (First State Pavlov Medical University of St. Petersburg. Raisa Gorbacheva Mem. Research Institute for Paediatric Oncology. Hematology. and Transplantation) ; Angelucci, E. (Department of Haematology. IRCCS Ospedale Policlinico San Martino) ; Ciceri, F. (Haematology and BMT) ; Blaise, D. (Programme de Transplantation and Therapie Cellulaire. Centre de Recherche en Cancérologie de Marseille. Institut Paoli Calmettes) ; Cornelissen, J.J. (Department of Hematology. Erasmus MC Cancer Institute. University Medical Center Rotterdam) ; Meijer, E. (Department of Hematology (Br 250). VU University Medical Center) ; Diez-Martin, J.L. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; Koc, Y. (Stem Cell Transplant Unit. Medical Park Hospitals) ; Rovira Tarrats, Montserrat (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Castagna, L. (Transplantation Unit. Department of Oncology and Haematology. Istituto Clinico Humanitas) ; Savani, B.N (Vanderbilt University Medical Center) ; Ruggeri, A. (Ospedale Pediatrico Bambino Gesù (Roma, Itàlia)) ; Nagler, A. (ALWP of the EBMT Office. Saint Antoine Hospital) ; Mohty, M. (Department of Hematology. Hopital Saint Antoine. Sorbonne University) ; Universitat Autònoma de Barcelona
Background: The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and matched unrelated (MUD) transplants. [...]
2020 - 10.1186/s13045-020-00882-6
Journal of hematology & oncology, Vol. 13 Núm. 1 (june 2020) , p. 46  
4.
11 p, 1.4 MB Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma / Timmerman, John (UCLA Medical Center) ; Herbaux, Charles (Centre Hospitalier Régional Universitaire de Lille) ; Ribrag, Vincent (Institut Gustave Roussy (Villejuif, França)) ; Zelenetz, Andrew D. (Memorial Sloan Kettering Cancer Center) ; Houot, Roch (Unité dʼInvestigation Clinique) ; Neelapu, Sattva S. (The University of Texas MD Anderson Cancer Center) ; Logan, Theodore (Indiana University) ; Lossos, Izidore S. (Sylvester Comprehensive Cancer Center) ; Urba, Walter (Providence Cancer Center) ; Salles, Gilles (Université de Lyon) ; Ramchandren, Radhakrishnan (Karmanos Cancer Institute) ; Jacobson, Caron (Harvard Medical School) ; Godwin, John (Providence Cancer Center) ; Carpio, Cecilia (Universitat Autònoma de Barcelona. Departament de Medicina) ; Lathers, Deanne (Bristol-Myers Squibb) ; Liu, Yali (Bristol-Myers Squibb) ; Neely, Jaclyn (Bristol-Myers Squibb) ; Suryawanshi, Satyendra (Bristol-Myers Squibb) ; Koguchi, Yoshinobu (Providence Cancer Center) ; Levy, Ronald (Stanford University School of Medicine)
Urelumab, a fully human, non-ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T-cell and natural killer-cell antitumor activity in preclinical models, and may enhance cytotoxic activity of rituximab. [...]
2020 - 10.1002/ajh.25757
American Journal of Hematology, Vol. 95 (february 2020) , p. 510-520  
5.
4 p, 736.7 KB Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia / Genescà, Eulàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Lazarenkov, A. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Morgades, Mireia. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Berbis, G. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ruíz-Xivillé, N. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gómez-Marzo, P. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ribera, J. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Juncà, J. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; González-Pérez, A. (Institute for Research in Biomedicine (IRB Barcelona)) ; Mercadal, Santiago (Clinical Hematology Service, Hospital Duran i Reynals-ICO, Hospitalet del LLobregat) ; Guardia, R. (Hospital Universitari de Girona Doctor Josep Trueta) ; Artola, M. T. (Hospital Universitario de Donostia. Clinical Hematology Service) ; Moreno, M. J. (Clinical Hematology Service, Hospital Vírgen de la Victoria) ; Martínez-López, J. (Hospital 12 de Octubre (Madrid)) ; Zamora, L. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Barba, Pere (Vall d'Hebron Institut d'Oncologia) ; Gil, Cristina (Clinical Hematology Service, Hospital General de Alicante) ; Tormo, M. (Hospital Clínic Universitari (València)) ; Cladera, A. (Clinical Hematology Service, Hospital Son Llàtzer) ; Novo, Andrés (Clinical Hematology Service, Hospital Son Espases) ; Pratcorona, M. (Institut d'Investigació Biomèdica Sant Pau) ; Nomdedeu, Josep (Institut d'Investigació Biomèdica Sant Pau) ; González-Campos, J. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Almeida, M. (Universidad de Salamanca. Banco Nacional de ADN Carlos III) ; Cervera, José (Instituto de Investigación Sanitaria La Fe (IIS La Fe)) ; Montesinos, Pau (Hospital Universitari i Politècnic La Fe de Valencia) ; Batlle, M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vives, S. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ; Feliu Frasnedo, Evarist (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Solé, F. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Orfao, A. (Hospital Clínico Universitario (Salamanca)) ; Ribera, J. M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Recurrent deletions of the CDKN2A/ARF/CDKN2B genes encoded at chromosome 9p21 have been described in both pediatric and adult acute lymphoblastic leukemia (ALL), but their prognostic value remains controversial, with limited data on adult T-ALL. [...]
2018 - 10.1186/s13045-018-0639-8
Journal of hematology & oncology, Vol. 11 (july 2018)  
6.
11 p, 623.1 KB Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia / Megías-Vericat, Juan Eduardo (Hospital Universitari i Politècnic La Fe de Valencia) ; Martínez-Cuadrón, David (Centro de Investigación Biomédica en Red de Cáncer) ; López, Joaquín Martínez (Hospital Universitario 12 de Octubre (Madrid)) ; Bergua, Juan Miguel (Hospital San Pedro de Alcántara) ; Tormo, Mar (Hospital Clínic Universitari (València)) ; Serrano, Josefina (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ; González, Ataulfo (Hospital Clínico San Carlos (Madrid)) ; de Oteyza, Jaime Pérez (Hospital Universitario HM Sanchinarro (Madrid)) ; Vives Polo, Susana (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Vidriales, Belén (Complejo Asistencial Universitario de Salamanca) ; Herrera, Pilar (Hospital Universitario Ramón y Cajal (Madrid)) ; Vera, Juan Antonio (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Martínez, Aurelio López (Hospital Arnau de Vilanova (València)) ; de la Fuente, Adolfo (MD Anderson Cancer Center, Madrid, Spain) ; Amador, Ma Lourdes (Hospital de Montecelo, Pontevedra, Spain) ; Hernández-Rivas, José-Ángel (Hospital Universitario Infanta Leonor) ; Fernández, Ma Ángeles (Hospital Xeral Cies, Vigo, Spain) ; Cerveró, Carlos Javier (Hospital Virgen de la Luz, Cuenca, Spain) ; Morillo, Daniel (Hospital Universitario Fundación Jiménez Díaz) ; Campo, Pilar Hernández (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Gorrochategui, Julián (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Primo, Daniel (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Rojas, José Luis (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Guenova, Margarita (Specialized Hospital for Active Treatment of Hematological Diseases, Sofía, Bulgaria) ; Ballesteros, Joan (Vivia Biotech, Tres Cantos, Madrid, Spain) ; Sanz, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ; Montesinos, Pau (Centro de Investigación Biomédica en Red de Cáncer) ; Universitat Autònoma de Barcelona
Induction schedules in acute myeloid leukemia (AML) are based on combinations of cytarabine and anthracyclines. The choice of the anthracycline employed has been widely studied in multiple clinical trials showing similar complete remission rates. [...]
2019 - 10.4084/MJHID.2019.016
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 11 (march 2019)  
7.
19 p, 21.3 MB An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination / Pallarès, Victor (Institut d'Investigació Biomèdica Sant Pau) ; Unzueta Elorza, Ugutz (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Falgàs, Aïda (Institut d'Investigació Biomèdica Sant Pau) ; Sánchez García, Laura (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Serna, Naroa (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Gallardo, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Morris, Gordon A. (University of Huddersfield. Department of Chemical Sciences) ; Alba-Castellón, Lorena (Institut d'Investigació Biomèdica Sant Pau) ; Álamo, Patricia (Institut d'Investigació Biomèdica Sant Pau) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Villaverde Corrales, Antonio (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Vázquez Gómez, Esther (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Casanova Rigat, Isolda (Institut d'Investigació Biomèdica Sant Pau) ; Mangues, Ramon (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Background: current acute myeloid leukemia (AML) therapy fails to eliminate quiescent leukemic blasts in the bone marrow, leading to about 50% of patient relapse by increasing AML burden in the bone marrow, blood, and extramedullar sites. [...]
2020 - 10.1186/s13045-020-00863-9
Journal of hematology & oncology, Vol. 13 issue 1 (April 2020) , art. 36  
8.
11 p, 1.8 MB Final analysis from RESONATE : Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma / Munir, T. (Department of Haematology. St. James's University Hospital) ; Brown, J.R. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; O'Brien, Susan (UC Irvine. Chao Family Comprehensive Cancer Center) ; Barrientos, J.C. (Northwell Health Cancer Institute (Estats Units d'Amèrica)) ; Barr, P.M. (Wilmot Cancer Institute. University of Rochester Medical Center) ; Reddy, N.M. (Vanderbilt-Ingram Cancer Center) ; Coutre, S. (Stanford Cancer Center. Stanford University School of Medicine) ; Tam, C.S. (Peter MacCallum Cancer Centre. St. Vincent's Hospital and University of Melbourne) ; Mulligan, S.P. (Royal North Shore Hospital) ; Jaeger, U. (Division of Hematology and Hemostaseology. Medical University of Vienna) ; Kipps, T.J. (UCSD Moores Cancer Center) ; Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ; Montillo, M. (Niguarda Ca' Granda Hospital) ; Burger, J.A. (Department of Leukemia. University of Texas MD Anderson Cancer Center) ; Byrd, J.C. (The Ohio State University Comprehensive Cancer Center) ; Hillmen, Peter (The Leeds Teaching Hospitals. St. James Institute of Oncology) ; Dai, S. (Pharmacyclics LLC. an AbbVie Company) ; Szoke, A. (Pharmacyclics LLC. an AbbVie Company) ; Dean, J.P. (Pharmacyclics LLC. an AbbVie Company) ; Woyach, J.A. (The Ohio State University Comprehensive Cancer Center) ; Universitat Autònoma de Barcelona
Ibrutinib, a once-daily oral inhibitor of Bruton's tyrosine kinase, is approved in the United States and Europe for treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). [...]
2019 - 10.1002/ajh.25638
American Journal of Hematology, Vol. 94 Núm. 12 (january 2019) , p. 1353-1363  
9.
9 p, 316.0 KB Treatment of Adolescent and Young Adults with Acute Lymphoblastic Leukemia / Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ribera Salas, Jordi (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Genescà, Eulàlia (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
The primary objective of this review was to update and discuss the current concepts and the results of the treatment of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA). After a brief consideration of the epidemiologic and clinicobiologic characteristics of ALL in the AYA population, the main retrospective comparative studies stating the superiority of pediatric over adult-based protocols were reviewed. [...]
2014 - 10.4084/mjhid.2014.052
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 6 (july 2014)  
10.
11 p, 858.6 KB Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation / Baron, Frédéric (Université de Liège (Bèlgica)) ; Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ; Ruggeri, Annalisa (Hôpital Saint-Louis (Paris, França)) ; Mohty, Mohamad (Hôpital Saint-Antoine (Paris, França)) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe de Valencia) ; Milpied, Noel (Hôpital Haut Léveque (Pessac, França)) ; Bacigalupo, Andrea (Ospedale Sant Martino (Genova, Itàlia)) ; Rambaldi, Alessandro (Azienda Ospedaliera Papa Giovanni XXIII (Bergamo, Itàlia)) ; Bonifazi, Francesca (Policlinico Sant'Orsola-Malpighi (Bologna, Itàlia)) ; Bosi, Alberto (Azienda Ospedaliero Universitaria Careggi (Firenze, Itàlia)) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Yakoub-Agha, Ibrahim (Hôpital Claude Huriez (Lille, França)) ; Ribera Santasusana, J. M. (José María) (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Gluckman, Eliane (Hôpital Saint-Louis (Paris, França)) ; Nagler, Arnon (Sheba Medical Center (Ramat Gran, Israel)) ; Universitat Autònoma de Barcelona
BACKGROUND: In the setting of allogeneic human leukocyte antigen (HLA)-matched bone marrow transplantation, transplanting male patients with grafts from female donors has been associated with a higher incidence of graft-versus-host disease (GVHD) and of nonrelapse mortality (NRM). [...]
2015 - 10.1186/s13045-015-0207-4
Journal of hematology & oncology, Vol. 8 Núm. 107 (october 2015)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.